PHAT Q3 2021 Earnings — Phathom Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

PHATPhathom Pharmaceuticals, Inc.

$831M

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$130,000

Operating Income

-$33M

Net Income

-$37M

EPS (Diluted)

$-0.98

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$29M

Free Cash Flow

-$29M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$228M

Total Liabilities

$125M

Stockholders' Equity

$103M

Cash & Equivalents

$225M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$130,000	$0	—
Operating Income	-$33M	-$33M	-0.9%
Net Income	-$37M	-$34M	-7.5%